This partnership aims to provide a new frontier in cancer care and vascular malformation treatment offering clinicians cutting-edge technology to improve patient outcomes SYDNEY Nov 18 2024 PRNewswire ...

Introduction/Background: Fibromuscular Dysplasia (FMD) is a non-atherosclerotic vascular disease that primarily affects medium-sized arteries and is characterized by ...

Minimally invasive techniques require only small incisions, reducing the likelihood of complications and promoting a quicker ...

Unexpected cardiovascular complications: Manipulating the neck can sometimes affect blood flow and lead to unexpected ...

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

Dementia describes symptoms like memory loss in multiple diseases, and Alzheimer’s is the most common form. Here are the key ...

DURHAM, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, ...

Vine weevil grubs live underground, so most of the damage they cause is going to initially appear on plant roots and the ...

Xeltis has developed aXess to improve on infection and reintervention rates compared to other dialysis access approaches.

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Each year, millions of catheters are used worldwide to treat vascular diseases, including heart problems and artery blockages. However, one common challenge during these procedures is the friction ...